Related Experiment Videos

Efficacy and safety of statin monotherapy in older adults: a meta-analysis

Caroline G P Roberts1, Eliseo Guallar, Annabelle Rodriguez

  • 1Division of Endocrinology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|August 19, 2007
PubMed

Insights

Statin therapy significantly lowers mortality and cardiovascular events like stroke and heart attack in older adults. These findings support offering statins to elderly individuals at high risk for atherosclerotic disease.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Statin therapy is proven to reduce cardiovascular events.
  • Older adults are less frequently prescribed statins due to perceived risks and lower cholesterol predictability.
  • This study addresses the efficacy of statins in the elderly population.

Purpose of the Study:

  • To evaluate the impact of statin therapy on all-cause mortality in older adults.
  • To assess the effect of statins on major cardiovascular events, including stroke, in elderly individuals.

Main Methods:

  • A meta-analysis was conducted on published randomized, placebo-controlled clinical trials.
  • Data included participants aged 60 years and older.
  • Outcomes extracted were mortality, cardiovascular events, and adverse events.

Main Results:

  • Statins reduced all-cause mortality by 15% and coronary heart disease (CHD) death by 23%.
  • Statin use decreased myocardial infarction (MI) risk by 26% and stroke risk by 24%.
  • No significant increase in cancer risk was observed; adverse event data were inconsistently reported.

Conclusions:

  • Statin therapy effectively reduces all-cause and CHD mortality, stroke, and MI in older adults.
  • Older patients at high risk for atherosclerotic disease should be considered for statin therapy.
  • Evidence supports broader statin prescription in the elderly population.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...